Dry eye sufferers may get relief by switching drops
NCT ID NCT07267481
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether switching from the dry eye drop Xiidra to a new drop called TRYPTYR (acoltremon 0.003%) can improve symptoms and tear production. About 100 adults with chronic dry eye who are already using Xiidra will take part. Researchers will measure tear production and symptom scores over 28 days to see if the switch helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- New imaging tools put to the test for measuring dry eye treatment effects
- Could your own blood cure dry eye? plasma drops put to the test
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable